Format

Send to

Choose Destination
Expert Rev Mol Med. 2009 Jan 20;11:e3. doi: 10.1017/S1462399409000957.

Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

Author information

1
Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA. gacabral@vcu.edu

Abstract

There is now a large body of data indicating that the cannabinoid receptor type 2 (CB2) is linked to a variety of immune events. This functional relevance appears to be most salient in the course of inflammation, a process during which there is an increased number of receptors that are available for activation. Studies aimed at elucidating signal transduction events resulting from CB2 interaction with its native ligands, and of the role of exogenous cannabinoids in modulating this process, are providing novel insights into the role of CB2 in maintaining a homeostatic immune balance within the host. Furthermore, these studies suggest that the CB2 may serve as a selective molecular target for therapeutic manipulation of untoward immune responses, including those associated with a variety of neuropathies that exhibit a hyperinflammatory component.

PMID:
19152719
PMCID:
PMC2768535
DOI:
10.1017/S1462399409000957
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Cambridge University Press Icon for PubMed Central
Loading ...
Support Center